BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 34503194)

  • 1. How to Differentiate Benign from Malignant Adrenocortical Tumors?
    Viëtor CL; Creemers SG; van Kemenade FJ; van Ginhoven TM; Hofland LJ; Feelders RA
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Interesting Case of Hepatic Adrenocortical Carcinoma.
    Permana H; Darmawan G; Ritonga E; Kusumawati M; Miftahurachman M; Soetedjo NN
    Acta Med Indones; 2018 Jul; 50(3):257-259. PubMed ID: 30333277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms.
    Patel D; Thompson MD; Manna SK; Krausz KW; Zhang L; Nilubol N; Gonzalez FJ; Kebebew E
    Clin Cancer Res; 2017 Sep; 23(17):5302-5310. PubMed ID: 28450405
    [No Abstract]   [Full Text] [Related]  

  • 4. Weiss criteria in large adrenocortical tumors: a validation study.
    Jain M; Kapoor S; Mishra A; Gupta S; Agarwal A
    Indian J Pathol Microbiol; 2010; 53(2):222-6. PubMed ID: 20551521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocortical cancer: pathophysiology and clinical management.
    Libè R; Fratticci A; Bertherat J
    Endocr Relat Cancer; 2007 Mar; 14(1):13-28. PubMed ID: 17395972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical assessment of histological diagnostic systems for adrenocortical tumors].
    Bokhyan VY; Pavlovskaya AI; Gubina GI; Stilidi IS
    Arkh Patol; 2015; 77(3):17-22. PubMed ID: 26226777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Past, Present and Future of Epigenetics in Adrenocortical Carcinoma.
    Ettaieb M; Kerkhofs T; van Engeland M; Haak H
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32414074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of Diagnostic Modalities for Adrenal Incidentaloma.
    Okroj D; Rzepecka A; Kłosowski P; Babińska A; Sworczak K
    J Clin Med; 2023 May; 12(11):. PubMed ID: 37297933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future directions in the diagnosis and medical treatment of adrenocortical carcinoma.
    Creemers SG; Hofland LJ; Korpershoek E; Franssen GJ; van Kemenade FJ; de Herder WW; Feelders RA
    Endocr Relat Cancer; 2016 Jan; 23(1):R43-69. PubMed ID: 26475053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas.
    Humbert AL; Lecoanet G; Moog S; Bouderraoui F; Bresler L; Vignaud JM; Chevalier E; Brunaud L; Klein M; Cuny T
    Endocrine; 2018 Mar; 59(3):529-537. PubMed ID: 29332161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-expression profiling of adrenocortical carcinoma.
    Suh I; Guerrero MA; Kebebew E
    Expert Rev Mol Diagn; 2009 May; 9(4):343-51. PubMed ID: 19441174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis.
    Ozsari L; Kutahyalioglu M; Elsayes KM; Vicens RA; Sircar K; Jazaerly T; Waguespack SG; Busaidy NL; Cabanillas ME; Dadu R; Hu MI; Vassilopoulou-Sellin R; Jimenez C; Lee JE; Habra MA
    Endocrine; 2016 Feb; 51(2):351-9. PubMed ID: 26206754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic dysregulation in adrenocortical carcinoma, a systematic review of the literature.
    Jonker PKC; Meyer VM; Kruijff S
    Mol Cell Endocrinol; 2018 Jul; 469():77-84. PubMed ID: 28830787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
    Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathologic features and expression of epidermal growth factor receptor and vascular endothelial growth factor in adrenocortical tumors].
    Wang CP; Zhang J; Gao J; Liu PP; Wu SF; Zeng X; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):686-90. PubMed ID: 23302311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical Carcinoma.
    Crowley MJ; Scognamiglio T; Liu YF; Kleiman DA; Beninato T; Aronova A; Liu H; Jhanwar YS; Molina A; Tagawa ST; Bander NH; Zarnegar R; Elemento O; Fahey TJ
    J Clin Endocrinol Metab; 2016 Mar; 101(3):981-7. PubMed ID: 26771706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adrenocortical cancer: morphological variants, immunohistochemical characteristics].
    Tkachuk AV; Tertychnyi AS; Beltsevich DG; Roslyakova AA; Belousov PV; Selivanova LS
    Arkh Patol; 2021; 83(3):10-18. PubMed ID: 33822549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Association of Clinical Endocrinology Disease State Clinical Review on the Evaluation and Management of Adrenocortical Carcinoma in an Adult: a Practical Approach.
    Kiseljak-Vassiliades K; Bancos I; Hamrahian A; Habra M; Vaidya A; Levine AC; Else T
    Endocr Pract; 2020 Nov; 26(11):1366-1383. PubMed ID: 33875173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy.
    Koperski Ł; Kotlarek M; Świerniak M; Kolanowska M; Kubiak A; Górnicka B; Jażdżewski K; Wójcicka A
    Oncotarget; 2017 Jul; 8(30):49191-49200. PubMed ID: 28423361
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.